| The availability of pharmacies in the United States: 2007–2015 DM Qato, S Zenk, J Wilder, R Harrington, D Gaskin, GC Alexander PloS one 12 (8), e0183172, 2017 | 184 | 2017 |
| Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study DP Kontoyiannis, H Yang, J Song, SS Kelkar, X Yang, N Azie, ... BMC infectious diseases 16, 1-6, 2016 | 131 | 2016 |
| Defining patient engagement in research: results of a systematic review and analysis: report of the ISPOR patient-centered special interest group RL Harrington, ML Hanna, EM Oehrlein, R Camp, R Wheeler, C Cooblall, ... Value in Health 23 (6), 677-688, 2020 | 103 | 2020 |
| Epidemiology and outcomes of hospitalizations with invasive aspergillosis in the United States, 2009–2013 MD Zilberberg, BH Nathanson, R Harrington, JR Spalding, AF Shorr Clinical Infectious Diseases 67 (5), 727-735, 2018 | 65 | 2018 |
| Drug-drug interaction associated with mold-active triazoles among hospitalized patients D Andes, N Azie, H Yang, R Harrington, C Kelley, RD Tan, EQ Wu, ... Antimicrobial agents and chemotherapy 60 (6), 3398-3406, 2016 | 59 | 2016 |
| Candidemia and invasive candidiasis among hospitalized neonates and pediatric patients R Harrington, SL Kindermann, Q Hou, RJ Taylor, N Azie, DL Horn Current medical research and opinion 33 (10), 1803-1812, 2017 | 43 | 2017 |
| Cost-effectiveness analysis of isavuconazole vs. voriconazole as first-line treatment for invasive aspergillosis R Harrington, E Lee, H Yang, J Wei, A Messali, N Azie, EQ Wu, J Spalding Advances in therapy 34, 207-220, 2017 | 42 | 2017 |
| An equity agenda for the field of health care quality improvement M O’Kane, S Agrawal, L Binder, V Dzau, TK Gandhi, R Harrington, K Mate, ... NAM perspectives 2021, 2021 | 41 | 2021 |
| Cost‐effectiveness analysis of sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction in the United States PM Zueger, VM Kumar, RL Harrington, GC Rigoni, A Atwood, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (5 …, 2018 | 31 | 2018 |
| The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation BJ Webb, R Harrington, J Schwartz, J Kammerer, J Spalding, E Lee, ... Transplant Infectious Disease 20 (5), e12961, 2018 | 29 | 2018 |
| The relationship between oseltamivir and suicide in pediatric patients R Harrington, S Adimadhyam, TA Lee, GT Schumock, JW Antoon The Annals of Family Medicine 16 (2), 145-148, 2018 | 24 | 2018 |
| A risk score for fluconazole failure among patients with candidemia L Ostrosky-Zeichner, R Harrington, N Azie, H Yang, N Li, J Zhao, V Koo, ... Antimicrobial Agents and Chemotherapy 61 (5), 10.1128/aac. 02091-16, 2017 | 21 | 2017 |
| Invasive Candida infections in a pediatric intensive care unit in Turkey: evaluation of an 11-year period N Aslan, D Yildizdas, D Alabaz, OO Horoz, A Yontem, E Kocabas Journal of Pediatric Intensive Care 9 (01), 021-026, 2020 | 19 | 2020 |
| Burden of hospitalizations over time with invasive aspergillosis in the United States, 2004–2013 MD Zilberberg, R Harrington, JR Spalding, AF Shorr BMC Public Health 19, 1-7, 2019 | 17 | 2019 |
| A primer on latent class analysis EH Law, R Harrington Value & Outcomes Spotlight 2 (6), 18-19, 2016 | 13 | 2016 |
| Impact of multimorbidity subgroups on the health care use of early pediatric cancer survivors RL Harrington, DM Qato, JW Antoon, RN Caskey, GT Schumock, TA Lee Cancer 126 (3), 649-658, 2020 | 11 | 2020 |
| Increasing uptake of comparative effectiveness and patient-centered outcomes research among stakeholders: insights from conference discussion E Law, R Harrington, GC Alexander, S Saha, E Oehrlein, EM Perfetto Journal of comparative effectiveness research 7 (2), 181-191, 2018 | 10 | 2018 |
| Multimorbidity and healthcare utilization among early survivors of pediatric cancer RL Harrington, DM Qato, JW Antoon, RN Caskey, GT Schumock, TA Lee Pediatric Blood & Cancer 66 (6), e27655, 2019 | 7 | 2019 |
| The Availability Of Pharmacies And Pharmacy Services In The United States: 2007-2015 D Qato, S Zenk, J Wilder, R Harrington, D Gaskin, C Alexander Value in Health 19 (3), A268, 2016 | 2 | 2016 |
| Attributes Defining Patient Engagement And Centeredness In Health Care Research And Practice: A Framework Developed By The Ispor Patient-Centered Special Interest Group ML Hanna, EM Oehrlein, EM Perfetto, V Astratinei, T Berner, LB Burke, ... Value in Health 19 (7), A487, 2016 | 1 | 2016 |
Dima QatoUniversity of Southern California在 usc.edu 的电子邮件经过验证
